Market Cap 1.37B
Revenue (ttm) 82.25M
Net Income (ttm) -20.18M
EPS (ttm) N/A
PE Ratio 2,754.00
Forward PE 550.80
Profit Margin -24.54%
Debt to Equity Ratio 0.03
Volume 267,900
Avg Vol 413,836
Day's Range N/A - N/A
Shares Out 47.91M
Stochastic %K 71%
Beta 1.95
Analysts Strong Sell
Price Target $31.30

Company Profile

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induc...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 425 402 1400
Fax: 425 402 1433
Address:
3303 Monte Villa Parkway, Suite 310, Bothell, United States
jpad
jpad Oct. 24 at 2:26 PM
$BLFS this was a $50/share stock
0 · Reply
Doozio
Doozio Oct. 23 at 1:25 PM
$BLFS chop chop huckleberries…. It was always on the DLO during 🐒🍌🧠⏰♾️
0 · Reply
jpad
jpad Oct. 21 at 11:27 AM
$BLFS can we go back over $30
0 · Reply
prismmarketview
prismmarketview Oct. 16 at 6:32 PM
The biotech equipment sector is entering a new growth cycle — projected to hit $144B by 2030, fueled by advances in cell & gene therapy, automation, and AI-driven manufacturing. Emergers like Cryoport ( $CYRX), Seer ( $SEER), and BioLife Solutions ( $BLFS) are powering this shift with innovations in cold-chain logistics, proteomics, and bioprocessing systems. https://prismmarketview.com/prism-bioview-dive-recent-report-projects-global-biotech-equipment-market-to-accelerate-toward-144bn-by-2030-heres-who-to-watch/
0 · Reply
jpad
jpad Oct. 16 at 12:03 AM
$BLFS going after the 52week high
0 · Reply
jpad
jpad Oct. 14 at 2:09 AM
$BLFS 08:52 AM EDT, 10/07/2025 (MT Newswires) -- BioLife Solutions (BLFS) said Tuesday it has sold its cold chain logistics subsidiary SAVSU Cleo Technologies to Peli BioThermal for $25.5 million in cash. Chairman and Chief Executive Roderick de Greef said the divestiture streamlines the company's product portfolio and operations "while focusing resources on creating shareholder value through high-margin recurring revenue."
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 9 at 5:34 PM
Results of list 9/26/25 $BLCO $BLD $BLDR $BLFS The list has 1 more day to go tomorrow. After an audit of 400 calls 291 hit the targets that's an 72.9% accuracy for the first 400 calls there is way more calls in the sheet any one that will want access to the Google sheet can sent me a private message and you can audit the rest of the Google sheet your self. 🔥 Cycle Trading Signal plugged into AI 🔥 list. @Stocktwits
0 · Reply
jpad
jpad Oct. 3 at 4:35 PM
$BLFS what made it go to 27 Let’s get back there
0 · Reply
jpad
jpad Sep. 18 at 11:37 AM
$BLFS after the rate cut it went down Hopefully it comes back today Still headed for $29
0 · Reply
jpad
jpad Sep. 15 at 11:53 AM
$BLFS no news and a big drop Why? Just profit takers Just let it go to $35
0 · Reply
Latest News on BLFS
BioLife: Back To Basics Is Getting Traction (Rating Upgrade)

Oct 1, 2025, 9:43 AM EDT - 24 days ago

BioLife: Back To Basics Is Getting Traction (Rating Upgrade)


BioLife Solutions, Inc. (BLFS) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 3:22 PM EDT - 2 months ago

BioLife Solutions, Inc. (BLFS) Q2 2025 Earnings Call Transcript


BioLife Solutions Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:03 PM EDT - 2 months ago

BioLife Solutions Reports Second Quarter 2025 Financial Results


BioLife Solutions Makes Strategic Investment in Pluristyx

Jul 28, 2025, 8:05 AM EDT - 3 months ago

BioLife Solutions Makes Strategic Investment in Pluristyx


BioLife Solutions, Inc. (BLFS) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:59 PM EDT - 6 months ago

BioLife Solutions, Inc. (BLFS) Q1 2025 Earnings Call Transcript


BioLife Solutions Updates Earnings Call Information

May 8, 2025, 4:32 PM EDT - 6 months ago

BioLife Solutions Updates Earnings Call Information


BioLife Solutions Reports First Quarter 2025 Financial Results

May 8, 2025, 4:03 PM EDT - 6 months ago

BioLife Solutions Reports First Quarter 2025 Financial Results


BioLife Solutions, Inc. (BLFS) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 10:23 AM EST - 8 months ago

BioLife Solutions, Inc. (BLFS) Q4 2024 Earnings Call Transcript


BioLife Is Cleaning Ship

Aug 20, 2024, 3:51 PM EDT - 1 year ago

BioLife Is Cleaning Ship


BioLife Solutions: A Complicated Tale

Nov 29, 2023, 3:06 PM EST - 2 years ago

BioLife Solutions: A Complicated Tale


BioLife Solutions, Inc. (BLFS) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 10:27 PM EST - 2 years ago

BioLife Solutions, Inc. (BLFS) Q3 2023 Earnings Call Transcript


BioLife Hit By An Inventory Correction

Aug 30, 2023, 8:58 AM EDT - 2 years ago

BioLife Hit By An Inventory Correction


jpad
jpad Oct. 24 at 2:26 PM
$BLFS this was a $50/share stock
0 · Reply
Doozio
Doozio Oct. 23 at 1:25 PM
$BLFS chop chop huckleberries…. It was always on the DLO during 🐒🍌🧠⏰♾️
0 · Reply
jpad
jpad Oct. 21 at 11:27 AM
$BLFS can we go back over $30
0 · Reply
prismmarketview
prismmarketview Oct. 16 at 6:32 PM
The biotech equipment sector is entering a new growth cycle — projected to hit $144B by 2030, fueled by advances in cell & gene therapy, automation, and AI-driven manufacturing. Emergers like Cryoport ( $CYRX), Seer ( $SEER), and BioLife Solutions ( $BLFS) are powering this shift with innovations in cold-chain logistics, proteomics, and bioprocessing systems. https://prismmarketview.com/prism-bioview-dive-recent-report-projects-global-biotech-equipment-market-to-accelerate-toward-144bn-by-2030-heres-who-to-watch/
0 · Reply
jpad
jpad Oct. 16 at 12:03 AM
$BLFS going after the 52week high
0 · Reply
jpad
jpad Oct. 14 at 2:09 AM
$BLFS 08:52 AM EDT, 10/07/2025 (MT Newswires) -- BioLife Solutions (BLFS) said Tuesday it has sold its cold chain logistics subsidiary SAVSU Cleo Technologies to Peli BioThermal for $25.5 million in cash. Chairman and Chief Executive Roderick de Greef said the divestiture streamlines the company's product portfolio and operations "while focusing resources on creating shareholder value through high-margin recurring revenue."
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 9 at 5:34 PM
Results of list 9/26/25 $BLCO $BLD $BLDR $BLFS The list has 1 more day to go tomorrow. After an audit of 400 calls 291 hit the targets that's an 72.9% accuracy for the first 400 calls there is way more calls in the sheet any one that will want access to the Google sheet can sent me a private message and you can audit the rest of the Google sheet your self. 🔥 Cycle Trading Signal plugged into AI 🔥 list. @Stocktwits
0 · Reply
jpad
jpad Oct. 3 at 4:35 PM
$BLFS what made it go to 27 Let’s get back there
0 · Reply
jpad
jpad Sep. 18 at 11:37 AM
$BLFS after the rate cut it went down Hopefully it comes back today Still headed for $29
0 · Reply
jpad
jpad Sep. 15 at 11:53 AM
$BLFS no news and a big drop Why? Just profit takers Just let it go to $35
0 · Reply
jpad
jpad Sep. 12 at 3:26 PM
$BLFS don’t give it all back today
0 · Reply
jpad
jpad Sep. 12 at 1:52 PM
$BLFS nobody talking
0 · Reply
jpad
jpad Sep. 10 at 6:13 PM
$BLFS it was only a couple years ago this stock was $50
0 · Reply
jpad
jpad Sep. 10 at 11:49 AM
$BLFS holding 26 Let’s make the push to 29
0 · Reply
jpad
jpad Sep. 5 at 2:07 PM
$BLFS up up up
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 4 at 9:27 AM
$BLFS Great piece that accurately captures BLFS's current position. So if you want to refresh your understanding of BLFS or learn about BLFS for the first time, this is essential reading. https://beyondspx.com/quote/BLFS/biolife-solutions-pure-play-focus-ignites-growth-and-margin-expansion-blfs#analysis
0 · Reply
GoBigD
GoBigD Sep. 2 at 8:35 PM
$BLFS Yes sir.
0 · Reply
HyperbolicHodler
HyperbolicHodler Aug. 23 at 7:37 AM
$BLFS BioLife Solutions Inc is a biopreservation company facing biotech funding environment challenges
0 · Reply
Rabinovich
Rabinovich Aug. 22 at 12:16 AM
$BLFS Right. I think with revenue of $80M per year this should be valued at $2B, in line with SRPT valuation, which has 15x higher revenues and FCF of $800M per year. Why not?
1 · Reply
jpad
jpad Aug. 15 at 2:20 AM
$BLFS let’s see what happens tomorrow up or down. Back to 26 then 29
0 · Reply
jpad
jpad Aug. 12 at 10:42 PM
$BLFS Zack’s upgraded to strong buy
0 · Reply
Rabinovich
Rabinovich Aug. 8 at 4:08 PM
$BLFS 12% up based on nothing. Gotta love this fraud.
0 · Reply